Last reviewed · How we verify

Azopt — Competitive Intelligence Brief

Azopt (Azopt) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Cardiovascular.

marketed Carbonic anhydrase 1, Carbonic anhydrase 12, Carbonic anhydrase 13 Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Azopt (Azopt) — Alcon Research.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Azopt TARGET Azopt Alcon Research marketed Carbonic anhydrase 1, Carbonic anhydrase 12, Carbonic anhydrase 13
Ethamide ETHOXZOLAMIDE Pfizer marketed ethoxzolamide Carbonic anhydrase 1, Carbonic anhydrase 12, Carbonic anhydrase 13 1982-01-01
Meldane coumafos marketed Carbonic anhydrase 1, Carbonic anhydrase 12, Carbonic anhydrase 13

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Azopt — Competitive Intelligence Brief. https://druglandscape.com/ci/azopt. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: